神州细胞股价下跌2.19% 融资余额增幅超95%

Core Insights - The stock price of ShenZhou Cell is reported at 71.40 yuan, down by 1.60 yuan or 2.19% from the previous trading day [1] - The company operates in the biopharmaceutical industry, focusing on the development of innovative biological drugs, including recombinant protein drugs and monoclonal antibody drugs for treating cancer and autoimmune diseases [1] - Recent data indicates a significant increase in ShenZhou Cell's financing balance, with a growth rate exceeding 95%, reflecting heightened market interest in the company [1] Trading Activity - On August 19, the net inflow of main funds was 139 million yuan, accounting for 0.44% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of funds reached 424 million yuan, representing 1.33% of the circulating market value [1] - The stock opened at 72.99 yuan, peaked at 78.84 yuan, and dipped to a low of 71.00 yuan, with a trading volume of 145,500 hands and a transaction amount of 1.087 billion yuan [1]